Anxiogenic and proconvulsant effect of gatifloxacin in mice

European Journal of Pharmacology

Volumn 580, Issue 1-2, 2008, Pages 130-134

  Bharal, Nidhi ^a   Gupta, Sparsh ^a   Khurana, Sonam ^a   Mediratta, Pramod Kumari ^a   Sharma, Krishna Kishore ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Anxiety; Gatifloxacin; Neurological effects

Indexed keywords

GATIFLOXACIN; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; COGNITION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FORCED SWIMMING TEST; GRIP STRENGTH; MALE; MAZE TEST; MEMORY; MOOD; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

ADMINISTRATION, ORAL; AFFECT; ANIMALS; ANTI-INFECTIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROQUINOLONES; HAND STRENGTH; MALE; MAZE LEARNING; MEMORY; MICE; PENTYLENETETRAZOLE; SEIZURES; SWIMMING; TIME FACTORS;

EID: 37649016870     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.10.035     Document Type: Article

References (51)

1. Akahane K., Sekiguchi M., Une T., and Osada Y. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid and receptor sites. Antimicrob. Agents Chemother. 33 (1989) 1704-1708
2. Akahane K., Kato M., and Takayama S. Involvement of inhibitory and excitatory neurotransmitters in levofloxacin and ciprofloxacin-induced convulsions in mice. Antimicrob. Agents Chemother. 37 (1993) 1764-1770
3. Anastasio G.D., Mensoe D., and Little J.M. Norfloxacin and seizures. Ann. Intern. Med. 109 (1988) 169-170
4. Beeler J.A., Prendergast B., and Zhuang X. Low amplitude entrainment of mice and the impact of circadian phase on behavior tests. Physiol. Behav. 87 (2006) 870-880
5. Bharal, N. 2004. Effects of sparfloxacin on CNS functions in mice. M. Pharm. Thesis. Department of Pharmacology, Jamia Hamdard, New Delhi-110062.
6. Bharal N., Pillai K.K., and Vohora D. Effects of sparfloxacin on CNS functions and urinary hydroxyproline in mice. Pharmacol. Res. 54 (2006) 111-117
7. Burkhardt O., Kohnlein T., Pap T., and Welte T. Recurrent tendonitis after treatment with two different fluoroquinolones. Scand. J. Infect. Dis. 36 (2004) 315-316
8. Carbon C. Comparison of side effects of levofloxacin versus other fluoroquinolones. Chemotherapy 47 (2001) 9-14
9. Christ W. Central nervous system toxicity of quinolones: human and animal findings. J. Antimicrob. Agents. Chemother. 26 (1990) 219-225
10. Christie M.J., Wong K., Ting R.H., Tam P.Y., and Sikaneta T.G. Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure. Ann. Pharmacother. 39 (2005) 953-955
11. Cohen J.S. Peripheral neuropathy associated with fluoroquinolones. Ann. Pharmacother. 35 (2001) 1-7
12. Davey P.G. An overview of drug interactions with the quinolones. J. Antimicrob. Chemother. 22 (1988) 97-107
13. De Sarro G., Nava F., Calapai G., and De Sarro A. Effects of some excitatory aminoacid antagonists and drugs enhancing gamma-amino butyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice. Antimicrob. Agents Chemother. 41 (1997) 427-434
14. Delon A., Huguet F., Courtis P., Vierford J.M., Beuquet S., and Couet W. Pharmacokinetic-phamacodynamic contribution to the convulsant activity of pefloxacin and norfloxacin in rats. J. Pharmacol. Exp. Ther. 280 (1997) 983-987
15. A and adenosine system in mammalian CNS. J. Pharmacol. Toxicol. 64 (1989) 404-411
16. Dunham N.W., and Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharma. Ass. 46 (1955) 208-209
17. Erden B.F., Ulak G., Yildiz F., Utkan T., Ozdemirci S., and Gacar N. Antidepressant, anxiogenic and antinociceptive properties of levofloxacin in rats and mice. Pharmacol. Biochem. Behav. 68 (2001) 435-441
18. Galatti L., Glustini S.E., Sessa A., Polimenio G., Spina E., and Caputi A.P. Neuropsychiatric reactions to drug: an analysis of spontaneous reports from general practitioners in Italy. Pharmacol. Res. 51 (2005) 211-216
19. A receptors by 4-quinolones. J. Antimicrob. Chemother. 31 (1993) 457-462
20. Harrel R.M. Fluoroquinolones-induced tendinopathy. South. Med. J. 92 (1999) 622-625
21. Hesslinger B., Hellwig B., Sester U., Walden J., and Berger M. An acute psychotic disorder caused by pefloxacin: a case report. Prog. Neuropsychopharmacol. Biol. Psychiatry. 20 (1996) 343-347
22. Huec L.J.C., Schaeverbeke T., Chauveaux D., et al. Epicondylitis after treatment with fluoroquinlone antibiotic. J. Bone Joint Surg. Br. 77 (1995) 293-295
23. Janknegt R. Drug interactions with quinolones. J. Antimicrob. Chemother. 26 (1990) 7s-29s
24. Khaliq Y., and Zhanel G.G. Fluoroquinlone-associated tendinopathy: a critical review of the literature. Clin. Infec. Dis. 36 (2003) 1404-1410
25. Kashida Y., and Kato M. Characterisation of fluoroquinolone-induced Achilles tendon toxicity in rats: comparison of toxicities of 10 fluoroquinolones and effects of anti-inflammatory compounds. Antimicrob. Agents Chemother. 41 (1997) 2389-2393
26. Kushner J.M., Peckman H.J., and Synder C.R. Seizures associated with fluoroquinolones. Ann. Pharmacother. 35 (2001) 1194-1198
27. Lucent J.C., Tilly H., Leropours G., Gress J., and Piguet H. Neurological toxicity related to pefloxacin. J. Antimicrob. Chemother. 21 (1988) 811-812
28. Marinella M.A. Myoclonus and generalized seizures associated with gatifloxacin treatment. Ann. Pharmacother. 35 (2001) 1194-1198
29. Mc Ewan S.R., and Davey P.G. Ciprofloxacin and tenosynovitis. Lancet 2 (1988) 900
30. Mc Garvey W.C., Singh D., and Trevino S.G. Partial Achilles tendon ruptures associated fluoroquinolone antibiotics: a case report and literature review. Foot Ankle Int. 17 (1996) 496-498
31. Melvani S., and Speed B.R. Alatrofloxacin-induced seizures during slow i.v. infusion. Ann. Pharmacother. 34 (2000) 1017-1019
32. Mulhall J.P., and Bergmann L.S. Ciprofloxacin induced acute psychosis. Urology 46 (1995) 102-103
33. Nakamura T., Fukuda H., Morita Y., Soumi K., and Kawamura Y. Pharmacological evaluation of garenoxacin, a novel des-F(6)-quinolone antimicrobial agent: effects on the central nervous system. J. Toxicol. Sci. 28 (2003) 35-45
34. Owens R.C., and Ambrose P.G. Antimicrobial safety: focus on fluoroquionolones. Clin. Infect. Dis. 2 (2005) 144-157 S
35. Pellow S., Phillipe C., File S., and Briley M. Validation of open: close arm entries in an elevated plus maze as a measure of anxiety in rat. J. Neurosci. Meth. 14 (1985) 149-167
36. Perry C.M., Barman Balfour J.A., and Lamb H.M. Gatifloxacin. Drugs 58 (1999) 683-696
37. Porsolt R.D., Berlin A., and Jalpre M. Behavioural despair in mice. A primary screening test of antidepressants. Arch. Int. Pharmacother. 239 (1997) 327-336
38. Quigley C.A., and Lederman J.A. Possible gatifloxacin-induced seizure. Ann. Pharmacother. 38 (2004) 235-237
39. Ragozzino M.E., Pal S.N., Unick K., Stefani M.R., and Gold P.E. Modulation of hippocampal acetylcholine release and spontaneous alternation scores by intrahippocampal glucose injections. J. Neurosci. 18 (1998) 1595-1601
40. Reeves R.R. Exacerbation of psychotic symptoms associated with gatifloxacin. Psychosomatics 48 (2007) 87
41. Rewari S., and Prabhu S.A. Comparative experimental study of proconvulsive potential of fluoroquinolones. Indian J. Pharmacol. 31 (1999) 29-32
42. Satyanarayana S., and Campbell B. Gatifloxacin-induced delirium and psychosis in an elderly demented woman. J. Am. Geriatr. Soc. 54 (2006) 871
43. Schmuck G., Schumann A., and Schluter. Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model. Antimicrob. Agents Chemother. 42 (1998) 1831-1836
44. Schwald N., and Debray-Meignan S. Suspected role of ofloxacin in a case of arthalgia, myalgia, and multiple tendinopathy. Rev. Rheum. Engl. Ed. 66 (1999) 419-421
45. Simpson K.J., and Brodie M. Convulsions related to enoxacin. Lancet 2 (1985) 161
46. A levels in conscious rats. Antimicrob. Agent Chemother. 46 (2002) 471-477
47. Stahlmann R., and Lode H. Toxicity of quinolones. Drugs 58 (1999) 37-42
48. Thomas R.J. Neurotoxicity of antibacterial therapy. South. Med. J. 87 (1994) 869-874
49. Vohora D., Pal S.N., and Pillai K.K. Modulation of spontaneous alternation behavior of mice treated with thioperamide and tacrine in a cross maze task. Fund. Clin. Pharmacol. 19 (2005) 531-532
50. Yamamoto K., Naitoh Y., Inoue Y., Yoshimura K., Merikawa K., Nagata O., Hashimoto S., Yamada T., and Kubo S. Seizure discharges induced by the combination of a new quinolones carboxylic acid antimicrobial drugs and non-steroidal anti-inflammatory drugs. Chemotherapy (Tokyo) 36 (1998) 300-324
51. Zhang L.R., Wang Y.M., Chen B.Y., and Cheng N.N. Neurotoxicity and toxicokinetics of norfloxacin in conscious rats. Acta Pharmacol. Sin. 24 (2003) 605-609